Open access · CC-BY
via OpenAlex
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, Aleksandra Kucharska-Lusina, Wioletta Rozpędek‐Kamińska, Ireneusz Majsterek
International Journal of Molecular Sciences · 2023 · ▲ 69 citations
Abstract
Parkinson's disease (PD) is a complex neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra and the widespread accumulation of alpha-synuclein (αSyn) protein aggregates. αSyn aggregation disrupts critical cellular processes, including synaptic function, mitochondrial integrity, and proteostasis(definition), which culminate in neuronal cell death. Importantly, αSyn pathology extends beyond neurons-it also encompasses spreading throughout the neuronal environment and internalization by microglia and astrocytes. Once internalized, glia can act as neuroprotective scavengers, which limit the spread of αSyn. However, they can also become reactive, thereby contributing to neuroinflammation and the progression of PD. Recent advances in αSyn research have enabled the molecular diagnosis of PD and accelerated the development of targeted therapies. Nevertheless, despite more than two decades of research, the cellular function, aggregation mechanisms, and induction of cellular damage by αSyn remain incompletely understood. Unraveling the interplay between αSyn, neurons, and glia may provide insights into disease initiation and progression, which may bring us closer to exploring new effective therapeutic strategies. Herein, we provide an overview of recent studies emphasizing the multifaceted nature of αSyn and its impact on both neuron and glial cell damage.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms25010360
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Saramowicz, K., Siwecka, N., Galita, G., Kucharska-Lusina, A., Rozpędek‐Kamińska, W., & Majsterek, I. (2023). Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms25010360
Vancouver
Saramowicz K, Siwecka N, Galita G, Kucharska-Lusina A, Rozpędek‐Kamińska W, Majsterek I. Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms25010360.
BibTeX
@article{kamil2023AlphaS,
title = {Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease},
author = {Kamil Saramowicz and Natalia Siwecka and Grzegorz Galita and Aleksandra Kucharska-Lusina and Wioletta Rozpędek‐Kamińska and Ireneusz Majsterek},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms25010360},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2024
Open access · CC-BY
Alpha Synuclein Toxicity and Non-Motor Parkinson’s
Molecular Neurobiology 2012
Open access · CC-BY
Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?
Acta Neurobiologiae Experimentalis 2019
Open access · CC-BY
The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson’s disease
Journal of Cellular and Molecular Medicine 2008
Preprint · OA
Immunological features of α‐synuclein in Parkinson's disease
Cell Research 2014
Open access · OA
EGF promotes mammalian cell growth by suppressing cellular senescence
bioRxiv (Cold Spring Harbor Laboratory) 2026
Preprint · CC-BY